surpass 3 tirzepatide 🔴Tirzepatide (Mounjaro) at a glance❤️🩺⤵️ 1. **SURPASS-1**: 🎉 reduced HbA1c & body weight 🏋️‍♂️ vs placebo. 2. **SURPASS-2**: 🌟 Tirzepatide beat semaglutide in HbA1c & weight loss. 3. **SURPASS-3**: Tirzepatide lowered Tirzepatide and muscle composition changes

Targeting more than one may pave the way to greater weight loss. A Well-Controlled Comparison The clinical trial was sponsored by Eli Lilly, the maker of tirzepatide, and included researchers from NewYork-Presbyterian, the University of Texas, UCLA, University College Dublin, and 32 clinical sites across the United States and Puerto Rico

Avoiding high-fat and greasy foods is critical, as these take the longest to digest and exacerbate the delayed gastric emptying effect

Transparency helps you feel confident about the commitment

Wagner, C

The rise in obesity rates growth contribution during the forecast period in 2025 is 4.5%